- Home
- IDA vs ADMA Comparison
IDA vs ADMA Comparison
Compare IDA & ADMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IDA
- ADMA
- Stock Information
- Founded
- IDA 1915
- ADMA 2004
- Country
- IDA United States
- ADMA United States
- Employees
- IDA N/A
- ADMA N/A
- Industry
- IDA Electric Utilities: Central
- ADMA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- IDA Utilities
- ADMA Health Care
- Exchange
- IDA Nasdaq
- ADMA Nasdaq
- Market Cap
- IDA 6.3B
- ADMA 5.1B
- IPO Year
- IDA N/A
- ADMA N/A
- Fundamental
- Price
- IDA $120.21
- ADMA $16.73
- Analyst Decision
- IDA Buy
- ADMA Strong Buy
- Analyst Count
- IDA 7
- ADMA 3
- Target Price
- IDA $122.86
- ADMA $27.67
- AVG Volume (30 Days)
- IDA 440.3K
- ADMA 2.9M
- Earning Date
- IDA 07-31-2025
- ADMA 08-07-2025
- Dividend Yield
- IDA 2.86%
- ADMA N/A
- EPS Growth
- IDA 12.96
- ADMA N/A
- EPS
- IDA 5.63
- ADMA 0.84
- Revenue
- IDA $1,810,154,000.00
- ADMA $459,381,000.00
- Revenue This Year
- IDA $5.33
- ADMA $21.42
- Revenue Next Year
- IDA $10.24
- ADMA $26.30
- P/E Ratio
- IDA $21.36
- ADMA $20.02
- Revenue Growth
- IDA 1.37
- ADMA 62.23
- 52 Week Low
- IDA $93.57
- ADMA $10.21
- 52 Week High
- IDA $120.84
- ADMA $25.67
- Technical
- Relative Strength Index (RSI)
- IDA 67.97
- ADMA 31.83
- Support Level
- IDA $117.18
- ADMA $17.90
- Resistance Level
- IDA $119.22
- ADMA $18.79
- Average True Range (ATR)
- IDA 1.72
- ADMA 0.69
- MACD
- IDA 0.43
- ADMA -0.03
- Stochastic Oscillator
- IDA 92.34
- ADMA 8.39
About IDA IDACORP Inc.
Idacorp Inc is a holding company that, through its subsidiaries, acts as an electric utility engaged in the generation, transmission, distribution, sale, and purchase of electric energy and capacity. The companys only reportable segment is utility operations. The utility operations segment's primary source of revenue is the regulated operations of Idaho Power. The company serves commercial and industrial customers, which involved in food processing, electronics and general manufacturing, agriculture, health care, government, and education.
About ADMA ADMA Biologics Inc
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.